Association of Myocardial Injury With Serum Procalcitonin Levels in Patients With ST-Elevation Myocardial Infarction
Authors: Martin Reindl, Christina Tiller, Magdalena Holzknecht, Ivan Lechner, Benjamin Henninger, Agnes Mayr, Christoph Brenner, Gert Klug, Axel Bauer, Bernhard Metzler, Sebastian J. Reinstadler
Journal: JAMA Network Open (2020)

<h3>Importance</h3> Myocardial tissue injury due to acute ST-elevation myocardial infarction (STEMI) initiates an inflammatory response that leads to a release of systemic inflammatory biomarkers, including C-reactive protein (CRP) and white blood cells, consequently reducing the usefulness of these routine biomarkers for identifying concomitant infections. The clinical role of procalcitonin (PCT), a promising marker of bacterial infection, to detect concomitant infection in acute STEMI is unknown, mainly because it is unclear whether myocardial injury per se induces systemic PCT release. <h3>Objective</h3> To investigate the release of serum PCT in the acute setting of STEMI (24 and 48 hours after primary percutaneous coronary intervention) and to elucidate any associations with myocardial injury markers through a comprehensive assessment by cardiac magnetic resonance (CMR) imaging. <h3>Design, Setting, and Participants</h3> This prospective cohort study conducted between 2016 and 2018 included 141 consecutive patients with STEMI treated with primary percutaneous coronary intervention. Concentrations of PCT, high-sensitivity CRP (hs-CRP), and high-sensitivity cardiac troponin T (hs-cTnT) and white blood cell counts were measured serially 24 and 48 hours after infarct. <h3>Exposures</h3> Acute STEMI and primary percutaneous coronary intervention. <h3>Main Outcomes and Measures</h3> The association of PCT and typical inflammatory marker levels with CMR-determined myocardial damage was assessed. Infarct size, extent of microvascular obstruction, and occurrence of intramyocardial hemorrhage as determined by CMR within the first week following STEMI were also evaluated. <h3>Results</h3> In total, 141 patients with STEMI (117 men [83%]) having a median age of 56 years (interquartile range, 50-66 years) were included. The median PCT concentration was 0.07 μg/L (interquartile range, &lt;0.06-0.11 μg/L) 24 hours after intervention and 0.07 μg/L (interquartile range, &lt;0.06-0.09 μg/L) 48 hours after intervention. Whereas hs-CRP and hs-cTnT levels and white blood cell counts were significantly correlated with CMR markers of myocardial damage at both 24 and 48 hours after intervention, the PCT level showed no significant correlation with infarct size (at 24 hours:<i>r</i> = 0.07;<i>P</i> = .40; at 48 hours:<i>r</i> = 0.13;<i>P</i> = .12) or with microvascular obstruction (at 24 hours:<i>r</i> = −0.03;<i>P</i> = .75; at 48 hours:<i>r</i> = 0.09;<i>P</i> = .30). Furthermore, PCT levels at 24 hours (odds ratio, 1.25; 95% CI, 0.63-2.48;<i>P</i> = .52) and 48 hours (odds ratio, 1.56; 95% CI, 0.72-3.41;<i>P</i> = .26) were not significantly associated with the presence of intramyocardial hemorrhage. <h3>Conclusions and Relevance</h3> In the acute phase after percutaneous coronary intervention for STEMI, circulating PCT levels remained unassociated with the extent of myocardial and microvascular tissue damage as visualized by CMR imaging.